Quelept-Quetiapine Fumarate

Product Description

Quetiapine fumarate is an atypical antipsychotic used in the management of schizophrenia and bipolar disorder. The portfolio includes immediate-release film-coated tablets and extended-release tablets, offering flexible dosing options for different treatment needs. Immediate-release tablets are available as 25 mg and 100 mg in packs of 30 tablets, and as 50 mg, 150 mg, 200 mg, 300 mg and 400 mg in packs of 30 or 60 tablets. Extended-release tablets are available as 50 mg in packs of 30 tablets, and as 150 mg, 200 mg, 300 mg and 400 mg in packs of 30 or 60 tablets. The broad range of strengths and formulations supports individualized dose initiation, titration and maintenance therapy according to patient needs and local prescribing information.

Ilko Ilac Sanayi ve Ticaret A.S

Country/Region:

Türkiye
Founded:

2012
On CPHI since:

2015
Certificates:

3
Employees:

1000 - 4999

Company types

Pharmaceutical company

Primary activities

Biopharmaceutical

OTC

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites

Specifications

Details

Therapeutic Area: Central Nervous System Therapeutic Class: Atypical Antipsychotic
Active Ingredient: Quetiapine Fumarate
Application Areas: Treatment of schizophrenia and bipolar disorder, including manic and depressive episodes. Certain strengths and formulations may also be used as adjunctive therapy in major depressive disorder, subject to the approved local prescribing information.
Selling Points
Sustainability
Model

Film Coated Tablet, Extended Release Tablet
Supplied from

Türkiye
Measured In
milligram; piece